BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Operating cash flow 2016–2025
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.0MFY2025 · since FY2016: -$5.9M → -$7.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.0M | +23.3% |
| FY2024 | -$9.1M | +55.6% |
| FY2023 | -$20.5M | -5.9% |
| FY2022 | -$19.3M | +26.4% |
| FY2021 | -$26.3M | +25.4% |
| FY2020 | -$35.2M | -212.9% |
| FY2019 | -$11.2M | +9.2% |
| FY2018 | -$12.4M | -424.0% |
| FY2017 | -$2.4M | +59.6% |
| FY2016 | -$5.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice